Received Mar 10, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Doctor advised not to take it, Allergic; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of allergy to vaccine in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced allergy to vaccine (Verbatim: Doctor advised not to take it, Allergic). The outcome of the allergy to vaccine was unknown. It was unknown if the reporter considered the allergy to vaccine to be related to Shingrix. It was unknown if the company considered the allergy to vaccine to be related to Shingrix. Additional Information: GSK Receipt Date: 03-MAR-2026 The batch number was not provided, and we are unable to contact the reporter.